Maternal SARS-COV-2 infection and prematurity: the Southern Michigan COVID-19 collaborative.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 24 5 2023
pubmed: 23 5 2023
entrez: 22 5 2023
Statut: ppublish

Résumé

COVID-19 has been reported to increase the risk of prematurity, however, due to the frequent absence of unaffected controls as well as inadequate accounting for confounders in many studies, the question requires further investigation. We sought to determine the impact of COVID-19 disease on preterm birth (PTB) overall, as well as related subcategories such as early prematurity, spontaneous, medically indicated preterm birth, and preterm labor (PTL). We assessed the impact of confounders such as COVID-19 risk factors, a-priori risk factors for PTB, symptomatology, and disease severity on rates of prematurity. This was a retrospective cohort study of pregnant women from March 2020 till October 1st, 2020. The study included patients from 14 obstetric centers in Michigan, USA. Cases were defined as women diagnosed with COVID-19 at any point during their pregnancy. Cases were matched with uninfected women who delivered in the same unit, within 30 d of the delivery of the index case. Outcomes of interest were frequencies of prematurity overall and subcategories of preterm birth (early, spontaneous/medically indicated, preterm labor, and premature preterm rupture of membranes) in cases compared to controls. The impact of modifiers of these outcomes was documented with extensive control for potential confounders. A The rate of prematurity was 8.9% in controls, 9.4% in asymptomatic cases, 26.5% in symptomatic COVID-19 cases, and 58.8% among cases admitted to the ICU. Gestational age at delivery was noted to decrease with disease severity. Cases were at an increased risk of prematurity overall [adjusted relative risk (aRR) = 1.62 (1.2-2.18)] and of early prematurity (<34 weeks) [aRR = 1.8 (1.02-3.16)] when compared to controls. Medically indicated prematurity related to preeclampsia [aRR = 2.46 (1.47-4.12)] or other indications [aRR = 2.32 (1.12-4.79)], were the primary drivers of overall prematurity risk. Symptomatic cases were at an increased risk of preterm labor [aRR = 1.74 (1.04-2.8)] and spontaneous preterm birth due to premature preterm rupture of membranes [aRR = 2.2(1.05-4.55)] when compared to controls and asymptomatic cases combined. The gestational age at delivery followed a dose-response relation with disease severity, as more severe cases tended to deliver earlier (Wilcoxon COVID-19 is an independent risk factor for preterm birth. The increased preterm birth rate in COVID-19 was primarily driven by medically indicated delivery, with preeclampsia as the principal risk factor. Symptomatic status and disease severity were significant drivers of preterm birth.

Identifiants

pubmed: 37217448
doi: 10.1080/14767058.2023.2199343
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2199343

Auteurs

Ray Bahado-Singh (R)

Department of Obstetrics and Gynecology, William Beaumont Hospital - Royal Oak, Royal Oak, MI, USA.

Adi L Tarca (AL)

Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.
Department of Obstetrics and Gynecology, School of Medicine, Wayne State University, Detroit, MI, USA.
Department of Computer Science, College of Engineering, Wayne State University, Detroit, MI, USA.

Yasmin G Hasbini (YG)

Office of Women's Health, Wayne State University, Detroit, MI, USA.

Robert J Sokol (RJ)

Department of Obstetrics and Gynecology, School of Medicine, Wayne State University, Detroit, MI, USA.

Madhurima Keerthy (M)

Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, MI, USA.

Gregory Goyert (G)

Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, MI, USA.

Theodore Jones (T)

Beaumont Hospital Dearborn, Dearborn, MI, USA.

Lisa Thiel (L)

Spectrum Health, Grand Rapids, MI, USA.

Pooja Green (P)

St Joseph Mercy Health System, Ann Arbor, MI, USA.

Youssef Youssef (Y)

Hurley Medical Center, Flint, MI, USA.

Courtney Townsel (C)

Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.

Shyla Vengalil (S)

Ascension St John Hospital, Detroit, MI, USA.

Paige Paladino (P)

Ascension Macomb-Oakland Hospital, Madison Heights, MI, USA.

Amy Wright (A)

St. Joseph Mercy Oakland, Trinity Health, Pontiac, MI, USA.

Mariam Ayyash (M)

Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, MI, USA.

Gayathri Vadlamud (G)

Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, MI, USA.

Marta Szymanska (M)

Department of Obstetrics and Gynecology, William Beaumont Hospital - Royal Oak, Royal Oak, MI, USA.

Sonia Sajja (S)

Department of Obstetrics and Gynecology, William Beaumont Hospital - Royal Oak, Royal Oak, MI, USA.

Onur Turkoglu (O)

Department of Obstetrics and Gynecology, William Beaumont Hospital - Royal Oak, Royal Oak, MI, USA.

Grace Sterenberg (G)

Spectrum Health, Grand Rapids, MI, USA.

Alexandra R Mangus (AR)

Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.

Micheal Baracy (M)

Ascension St John Hospital, Detroit, MI, USA.

Maria Gibbons (M)

Ascension St John Hospital, Detroit, MI, USA.

Karlee Grace (K)

Ascension Macomb-Oakland Hospital, Madison Heights, MI, USA.

Kaitlyn Houston (K)

Ascension Macomb-Oakland Hospital, Madison Heights, MI, USA.

Jessica Norman (J)

St. Joseph Mercy Oakland, Trinity Health, Pontiac, MI, USA.

Dereje W Gudicha (DW)

Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.
Department of Obstetrics and Gynecology, School of Medicine, Wayne State University, Detroit, MI, USA.

Sonia S Hassan (SS)

Department of Obstetrics and Gynecology, School of Medicine, Wayne State University, Detroit, MI, USA.
Office of Women's Health, Wayne State University, Detroit, MI, USA.
Department of Physiology, School of Medicine, Wayne State University, Detroit, MI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH